Mary Caffrey

The study appeared as one of its authors testified before Congress on the high cost of prescription drugs, including insulin. Experts told the House Committee on Oversight and Reform that branded drug makers enjoy monopolies and that barriers to competition harm consumers.

The National Institutes of Health halted the landmark SPRINT study in 2015 after results clearly showed a cardiovascular benefit for patients who had their systolic blood pressure aggressively controlled to 120 mm/Hg.

The study counted all kinds of activity, including walking to work, repairs around the house, and, of course, sports.

The partnership will seek repeatable, scalable models to present at a summit later this year.

A nurse at the Cleveland Clinic launched the initiative after mothers asked to delay their newborns' baths to increase their ability to take to nursing.

The study is first to measure sleep along with spread of atherosclerosis throughout the body, according to the American College of Cardiology.

Keeping patients with diabetes motivated is the most challenging part of exercise, the authors say, as they call for psychologists and counselors to be part of the care team.

While depression and diabetes have been linked previously, the study from Hong Kong examined the effects of an early diagnosis of type 2 diabetes on hospitalization over time.

Authors noted that because experiments are typically done only on male mice, this brain signaling pathway controlling bone growth had never been discovered.

Rather than offer support, physicians often reinforced the women's feeling of not being in control of their decisions, according to a study looking at why obese women are less likely to start or keep breastfeeding.

The analysis discusses the strength of evidence that SGLT2 inhibitors have a class effect in preventing heart failure for patients with diabetes.

Research and regulatory gaps in the use of marijuana will only grow unless the scientific community and policy leaders fill the void, according to a commentary series in Annals of Internal Medicine on marijuana’s rising availability.

The initial trial made news because the results were at odds with ACCORD. This new analysis highlights the need for personalized diabetes care, especially among older adults.

Publishing a list of conditions for which long-acting birth control is medically indicated increased uptake among women in Medicaid, but overall use remains low.

Findings in Hypertension, published by the American Heart Association, suggest a need to identify those at early risk of dementia.

With everyone carrying a smartphone, there's no reason why digital health tools and apps cannot be leveraged to hold at-risk patients accountable for cardiovascular health.

A statement on hypoglycemia, an consensus document from cardiologists on diabetes and CVD, and guidelines on treating cholesterol.

The Commonwealth Fund report compared the status of health and healthcare for women in the United States to that of 10 other wealthy countries, including the United Kingdom, Canada, Germany, and Australia.

Concerns over cost should lead FDA to recommend adjustments to these trials, which many say have led to unexpected knowledge and changed the field of diabetes care.

From chimeric antigen receptor T-cell therapy to value-based contracting, reimbursement issues dominated reader interest.

Leading cardiologist Mikhail N. Kosiborod, MD, FACC, FAHA, discusses how the FDA's 2008 guidance requiring cardiovascular outcomes trials has changed the treatment landscape in diabetes care and what expectations might look like going forward.

Technology and issues with reimbursement with of interest to authors writing for our diabetes journal this year.

Dublin, Ireland-based S3 Connected Health discusses the need to identify barriers to healthy behavior as well as factors that can promote healthy actions.

The COORDINATE-Diabetes seeks to explore what happens between development of clinical guidelines and their translation into clinical practice.

The relationship between diabetes management and preventing cardiovascular events was a theme throughout 2018, and this is reflected in the new standards.

In the past, data-gathering on pregnancy-related deaths has been irregular and review committees have not always addressed prevention.

The 2019 Standards of Care reflect an ongoing collaboration between the American Diabetes Association and the American College of Cardiology.

Many commentators disagreed with the argument that the call for a penalty to enforce the individual mandate could not stand apart from other parts of the law, such as protections to cover pre-existing conditions.